Bharat Biotech said it had received government permission to go ahead with the first two phases of clinical trials after initial studies demonstrated ...
News
- Asia Today: India's virus cases, deaths surge again
- BiOasis: Fiscal 4Q Earnings Snapshot
The biotech drug developer posted revenue of $26,100 in the period. Its adjusted revenue was $26,000. For the year, the company reported that its loss ...
- Power outage: Research offers hint about heart weakness in Barth syndrome
The University of Texas Health Science Center at San Antonio, also ... health professions and graduate biomedical sciences have graduated more ...
- The Latest: Jacksonville enacts mandatory mask requirement
The Mainz-based biotechnology company said Monday that the investment will take the form of about $139 million in ordinary shares and $112 million ...
- Heron earns a second slapdown from the FDA on pain med — shares wither
Intercept wasn't the only biotech in line for a drubbing today. ... Biopharma, a tiny immuno-oncology startup based in San Antonio, filed for $25 million.